Global Reach Zai Lab has a global presence with operations in both China and the United States, offering sales opportunities in two significant markets for biopharmaceutical products.

Diverse Therapeutic Focus With a focus on oncology, autoimmune disorders, infectious diseases, and neurological disorders, Zai Lab's diverse portfolio provides a wide range of sales opportunities to address various unmet medical needs.

Commercial-Stage Company Being a commercial-stage biopharmaceutical company indicates that Zai Lab already has products in the market, offering immediate sales opportunities to engage with healthcare providers and expand market share.

Robust Funding With substantial funding of $858 million and revenue in the range of $100 million to $1 billion, Zai Lab has the financial stability to support long-term sales initiatives and product development.

Competitive Landscape By comparing Zai Lab to similar companies like Legend Biotech, Innovent Biologics, and CStone Pharmaceuticals in terms of employees and revenue, a sales strategy can be developed to differentiate and position Zai Lab effectively in the market.